Reemergence of Macrolide Resistance in Pharyngeal Isolates of Group A Streptococci in Southwestern Pennsylvania

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 2, 2004, Pages 473-476

  Green, Michael ^a   Martin, Judith M ^a   Barbadora, Karen A ^a   Beall, Bernard ^b   Wald, Ellen R ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLONE; DRUG EFFECT; EMM GENE; ERM GENE; FIELD INVERSION GEL ELECTROPHORESIS; GEL ELECTROPHORESIS; GENE SEQUENCE; GENOTYPE; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; LONGITUDINAL SURVEILLANCE; MEF GENE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION 50; MONITORING; NONHUMAN; PEDIATRIC HOSPITAL; PEDIATRICS; PHARYNX; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PRIVATE PRACTICE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THROAT CULTURE; UNITED STATES;

ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENNSYLVANIA; PHARYNX; PHENOTYPE; POPULATION SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0942268849     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.2.473-476.2004     Document Type: Article

References (33)

1. Alos, J. I., B. Aracil, J. Oteo, C. Torres, J. L. Gomez-Garces, et al. 2000. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. J. Antimicrob. Chemother. 45:605-609.
2. American Academy of Pediatrics. 2003. Group A streptococcal infections, p. 526-536. In Redbook: report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, Ill.
3. Banks, B. J., S. Porcella, K. Barbian, J. Martin, and J. Musser. J. Infect. Dis., in press.
4. Barry, A. L., M. A. Pfaller, R. P. Rennie, P. C. Fuchs, and S. D. Brown. 2002. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob. Agents Chemother. 46:1781-1784.
5. Bassetti, M., G. Manno, A. Collida, A. Ferrando, G. Gatti, E. Ugolotti, M. Cruciani, and D. Bassetti. 2000. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg. Infect. Dis. 6:180-183.
6. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
7. Bisno, A. L. 1991. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325:783-793.
8. Bisno, A. L., M. A. Gerber, J. M. Gwaltney, Jr., E. L. Kaplan, and R. H. Schwartz. 1997. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin. Infect. Dis. 25:574-583.
9. Centers for Disease Control and Prevention. 2001. National Center for Health Statistics, National Ambulatory Medical Care Survey, 1999 Summary. Centers for Disease Control and Prevention, Hyattsville, Md. [Online.] www.cdc.gov/nchs/data/ad/ad322.pdf. (Accessed 9 July 2003.)
10. Cizman, M., M. Pokorn, K. Seme, A. Orazem, and M. Paragi. 2001. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47:475-477.
11. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
12. Coonan, K. M., and E. L. Kaplan. 1994. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. J. 13:630-635.
13. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, R. Fontana, et al. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
14. Cresti, S., M. Lattanzi, A. Zanchi, F. Montagnani, S. Pollini, C. Cellesi, and G. M. Rossolini. 2002. Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. Antimicrob. Agents Chemother. 46:1816-1822.
15. Critchley, I. A., D. F. Sahm, C. Thornsherry, R. S. Blosser-Middleton, M. E. Jones, and J. A. Karlowsky. 2002. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Diagn. Microbiol Infect. Dis. 42:129-135.
16. Freeman, A. F., and S. T. Shulman. 2002. Macrolide resistance in group A streptococcus. Pediatr. Infect. Dis. J. 21:1158-1160.
17. Fujita, K., K. Murono, M. Yoshikawa, and T. Murai. 1994. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13:1075-1078.
18. Gay, K., and D. S. Stephens. 2001. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J. Infect. Dis. 184:56-65.
19. Kaplan, E. L. 1997. Recent evaluation of antimicrobial resistance in beta-hemolytic streptococci. Clin. Infect. Dis. 24(Suppl. 1):S89-S92.
20. Kaplan, E. L., D. R. Johnson, M. C. Del Rosario, and D. L. Horn. 1999. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr. Infect. Dis. J. 18:1069-1072.
21. Li, Z., V. Akota, D. Jackson, A. R. Franklin, B. Beall, et al. 2003. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J. Infect. Dis. 188:1587-1592.
22. Martin, J. M., M. Green, K. A. Barbadora, and E. R. Wald. 2002. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346:1200-1206.
23. Martin, J. M., E. R. Wald, and M. Green. 1998. Field inversion gel electrophoresis as a typing system for group A streptococcus. J. Infect. Dis. 177:504-507.
24. National Committee for Clinical Laboratory Standards. 2000. Performance standards for susceptibility testing: tenth informational supplement. M100-S10 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. Palavecino, E. L., I. Riedel, X. Berrios, S. Bajaksouzian, D. Johnson, E. Kaplan, and M. R. Jacobs. 2001. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob. Agents Chemother. 45:339-341.
26. Santagati, M., F. Iannelli, M. R. Oggioni, S. Stefani, and G. Pozzi. 2000. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:2585-2587.
27. Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, P. Huovinen, et al. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.
28. Seppala, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
29. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
30. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
31. Varaldo, P. E., E. A. Debbia, G. Nicoletti, D. Pavesio, S. Ripa, G. C. Schito, G. Tempera, et al. 1999. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Clin. Infect. Dis. 29:869-873.
32. Yan, J. J., H. M. Wu, A. H. Huang, H. M. Fu, C. T. Lee, and J. J. Wu. 2000. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.
33. York, M. K., L. Gibbs, F. Perdreau-Remington, and G. F. Brooks. 1999. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J. Clin. Microbiol. 37:1727-1731.